Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Case Rep Pathol ; 2011: 314696, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22937383

RESUMEN

Fanconi-Bickel Syndrome (FBS) is a rare variety of glycogen storage disease (GSD). Characterized by massive hepatomegaly due to glycogen accumulation, severe hypophosphatemic rickets, and marked growth retardation due to proximal renal tubular dysfunction. We report a young boy presented as hypophosphatemic rickets with hepatomegaly and subsequently diagnosed as FBS.

2.
Cancer Lett ; 250(1): 107-16, 2007 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-17084521

RESUMEN

The efficacy of Onconase on the growth of a panel of chemosensitive and chemoresistant neuroblastoma cell lines was investigated. Onconase decreased cell viability of chemosensitive (IMR-32, UKF-NB-3) and chemoresistant neuroblastoma cell lines characterised by high expression of P-glycoprotein (P-gp) (UKF-NB-3(r)DOX(20)) or by high P-gp expression in combination with mutated p53 (UKF-NB-3(r)VCR(10), Be(2)-C), in a similar manner. Moreover, Onconase caused cell cycle block in G1 phase and induced caspase-independent cell death. Transmission electron microscope investigations suggested that Onconase-induced autophagy contributes to Onconase-induced cell death. Antitumour activity of Onconase against naïve and drug-resistant neuroblastoma xenografts was confirmed in animals.


Asunto(s)
Antineoplásicos/farmacología , Caspasas/metabolismo , Resistencia a Antineoplásicos , Neuroblastoma/tratamiento farmacológico , Ribonucleasas/farmacología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/análisis , Animales , Ciclo Celular , Muerte Celular , Supervivencia Celular/efectos de los fármacos , Femenino , Humanos , Ratones , Ratones Desnudos , Neuroblastoma/patología , Células Tumorales Cultivadas , Ensayos Antitumor por Modelo de Xenoinjerto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...